[1] |
ZHANG Li-jie*, HAN Xi-qin, WANG Jing-ping, CHEN Yu-hui, CHEN Sheng-yu, CHEN Ling, LI Bo, LIN Ming-gui, LI You-lun, SHI Lian, XI Xiu-e, MA Li-ping, WANG Xin, WANG Fei, ZHAO Cai-yan, WANG Fu-rong, CHEN Sen-lin, WU Xiang, LI Po, ZHANG Peng, LENG Xue-yan, ZHANG Hai-qing, CAO Wen-li, SHU Wei, SUN Yu-xian, XIE Shi-heng, TIAN Xi-zhong, HUANG Xue-rui, DU Jian, GAO Wei-wei.
The relationship between bacterial load and treatment failure and recurrence of sputum positive retreatment pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2021, 43(4): 335-340.
|
[2] |
ZHANG Chen-chen*, TAN Wei-guo, GUO Hui-xin, HUANG Xin-chun, CHEN Yan-mei, WEI Wen-jing.
The effect of Mycobacterium tuberculosis infection on sputum flora structure
[J]. Chinese Journal of Antituberculosis, 2021, 43(4): 357-363.
|
[3] |
BAI Hua, GUO Jing-wei, HU Pei-lei, YI Song-lin, WEN Jia, LIU Feng-ping, TAN Yun-hong, BAI Li-qiong.
Analysis of drug resistance surveillance results of Mycobacterium tuberculosis in Hu’nan Province from 2014 to 2018
[J]. Chinese Journal of Antituberculosis, 2021, 43(4): 364-369.
|
[4] |
HE Yi-jun, ZHANG Hao-ran, XIN He-nan, GAO Lei.
Optimizing the application of tuberculin skin test
[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 204-210.
|
[5] |
DUAN Hui-juan, CHU Hong-qian, KONG Cheng-cheng, DAI Guang-ming, CAO Ting-ming, SUN Zhao-gang.
Evaluation of the effect of skin reaction on 11 Mycobacterium tuberculosis antigens
[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 255-260.
|
[6] |
ZHANG Chun-xia, XU Gui-sheng, SHI Jin-yan.
Research progress on diagnostic methods of multidrug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(3): 291-294.
|
[7] |
WANG Pei, ZHAO Guo-lian, LEI Qian, ZHENG Dan, CUI Xiao-li, ZHOU Jun.
Comparison of the clinical application between fluorescence PCR probe melting curve and Micropore-plate method in determining the drug resistance of Mycobacterium tuberculosis
[J]. Chinese Journal of Antituberculosis, 2021, 43(2): 132-138.
|
[8] |
WANG Xiu-jun, LIU Qiu-yue, CHEN Xiao-feng, YU Lei, MA Yan, HAN Fen.
Study on plasma proteomics of patients with secondary pulmonary tuberculosis based on label-free quantitative technology
[J]. Chinese Journal of Antituberculosis, 2021, 43(2): 159-165.
|
[9] |
GUO Qian, SHEN Chen, SHEN A-dong.
Research progress of stem cells in Mycobacterium tuberculosis infection
[J]. Chinese Journal of Antituberculosis, 2021, 43(2): 186-189.
|
[10] |
LIU Zhi-bin, WU Min, WU Xiao-cui, HAN Min, XIAO He-ping, ZHANG Qing.
The value of PCR-reverse dot blot hybridization in detecting the drug resistance of Mycobacterium tuberculosis in sputum specimens of retreatment smear-positive pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2021, 43(1): 47-51.
|
[11] |
Chinese Antituberculosis Association.
Tuberculosis research progress in 2020
[J]. Chinese Journal of Antituberculosis, 2021, 43(1): 6-11.
|
[12] |
Chinese Antituberculosis Association, Schools and Children Branch of the Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis .
Expert consensus of clinical application of the recombinant Mycobacterium tuberculosis fusion protein (EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 761-768.
|
[13] |
YANG Lei, WEI Fen, ZHANG Kai, QIU Jing-jing, WANG Ying-ying, DU Wei-xin, LU Jin-biao, TAO Li-feng, PU Jiang.
Stability and efficacy study of recombinant Mycobacterium tuberculosis fusion protein (EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 799-806.
|
[14] |
ZHANG Kai, TAO Li-feng, WEI Fen, DU Wei-xin, QIU Jing-jing, CHEN Wei, CHEN Bao-wen, ZHU Yin-meng, CHENG Xing, SU Cheng, ZHONG Zai-xin, LU Jin-biao, PU Jiang.
Immune characteristics and preclinical animal safety studies of recombinant Mycobacterium tuberculosis fusion protein(EC)
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 807-813.
|
[15] |
ZHANG Kai, SHEN Xiao-bing, TAO Li-feng, WEI Fen, CHEN Bao-wen, QIU Jing-jing, CHEN Wei, LU Jin-biao, ZHU Yin-meng, CHENG Xing, ZHONG Zai-xin, ZHAO Ai-Hua, PU Jiang.
Establishment of quality standards for recombinant Mycobacterium tuberculosis fusion protein
[J]. Chinese Journal of Antituberculosis, 2020, 42(8): 814-820.
|